Diabetes Complications  >>  Tekturna (aliskiren)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT00097955: Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Completed
2
496
US, Canada, Europe, RoW
aliskiren
Novartis Pharmaceuticals
Diabetic Nephropathy
04/07
04/07

Download Options